Ipr Drug Patent Portfolio

Ipr owns 2 orange book drugs protected by 14 US patents Given below is the list of Ipr's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6858618 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia 17 Jun, 2022 Expired
US6858618 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia 17 Dec, 2021 Expired
US6316460 Pharmaceutical compositions 04 Feb, 2021 Expired
US6316460 Pharmaceutical compositions 04 Aug, 2020 Expired
US7030152 Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease 02 Oct, 2018 Expired
US7964614 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease 02 Oct, 2018 Expired
US7030152 Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease 02 Apr, 2018 Expired
US7964614 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease 02 Apr, 2018 Expired
USRE37314 Pyrimidine derivatives 08 Jul, 2016 Expired
USRE37314 Pyrimidine derivatives 08 Jan, 2016 Expired
US5466699 Indolyl compounds for treating migraine 14 May, 2013 Expired
US5863935 Therapeutic heterocyclic compounds 14 May, 2013 Expired
US5466699 Indolyl compounds for treating migraine 14 Nov, 2012 Expired
US5863935 Therapeutic heterocyclic compounds 14 Nov, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Ipr.

Activity Date Patent Number
Patent litigations
Expire Patent 29 Jul, 2019 US7964614
Maintenance Fee Reminder Mailed 11 Feb, 2019 US7964614
Payment of Maintenance Fee, 12th Year, Large Entity 08 Nov, 2018 US7220767 (Litigated)
Request for Trial Denied 02 Feb, 2016 US7220767 (Litigated)
Request for Trial Denied 27 Jan, 2016 US6750237 (Litigated)
Patent Issue Date Used in PTA Calculation 21 Jun, 2011 US7964614
Recordation of Patent Grant Mailed 21 Jun, 2011 US7964614
Issue Notification Mailed 01 Jun, 2011 US7964614
Dispatch to FDC 19 May, 2011 US7964614
Mail Response to 312 Amendment (PTO-271) 18 May, 2011 US7964614
Application Is Considered Ready for Issue 16 May, 2011 US7964614
Response to Amendment under Rule 312 16 May, 2011 US7964614
Issue Fee Payment Verified 22 Apr, 2011 US7964614
Issue Fee Payment Received 22 Apr, 2011 US7964614
Mail Miscellaneous Communication to Applicant 20 Apr, 2011 US7964614


Ipr's Family Patents


Family Patents



Ipr Drug List

Given below is the complete list of Ipr's drugs and the patents protecting them.


1. Crestor

Crestor is protected by 10 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6858618
(Pediatric)
Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia 17 Jun, 2022
(2 years ago)
Expired
US6858618 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia 17 Dec, 2021
(2 years ago)
Expired
US6316460
(Pediatric)
Pharmaceutical compositions 04 Feb, 2021
(3 years ago)
Expired
US6316460 Pharmaceutical compositions 04 Aug, 2020
(4 years ago)
Expired
US7030152
(Pediatric)
Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease 02 Oct, 2018
(6 years ago)
Expired
US7964614
(Pediatric)
Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease 02 Oct, 2018
(6 years ago)
Expired
US7030152 Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease 02 Apr, 2018
(6 years ago)
Expired
US7964614 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease 02 Apr, 2018
(6 years ago)
Expired
USRE37314
(Pediatric)
Pyrimidine derivatives 08 Jul, 2016
(8 years ago)
Expired
USRE37314 Pyrimidine derivatives 08 Jan, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Crestor's drug page


2. Zomig

Zomig is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5466699
(Pediatric)
Indolyl compounds for treating migraine 14 May, 2013
(11 years ago)
Expired
US5863935
(Pediatric)
Therapeutic heterocyclic compounds 14 May, 2013
(11 years ago)
Expired
US5466699 Indolyl compounds for treating migraine 14 Nov, 2012
(11 years ago)
Expired
US5863935 Therapeutic heterocyclic compounds 14 Nov, 2012
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zomig's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ipr News

Addressing Legal Obstacles While Advancing India's Pharmaceutical Industry

25 Jan, 2024

See More